1. Kirloskar Launches Non-Invasive MRgFUS in India
(Communities/Ultrasound)

Kirloskar Technologies Launches Non- Invasive Magnetic Resonance guided Focused Ultrasound System (MRgFUS) in India, Jaslok Mumbai the first hospital to install ExAblate 2000. With the launch of ExAblate ...

2. InSightec’s ExAblate MRgFUS for Uterine Fibroids
(Company News/InSightec)

InSightec Ltd. announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the company’s ExAblate MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine ...

3. InSightec Announces Three Studies Supporting Use of ExAblate & MRgFUS
(Company News/InSightec)

... and durable treatment for uterine fibroids. One study showed that non-invasive treatment with the ExAblate Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system offers women a significantly less ...

4. University of Virginia Researchers Ready to Help Revolutionize Medical Care Worldwide
(Communities/MRI)

Most Americans have never heard of magnetic resonance guided focused ultrasound (MRgFUS), yet it is a technology that promises to revolutionize medical care around the world. Neal F. Kassell, The professor ...

5. A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients with Functional Brain Disorders
(Company News/InSightec)

InSightec announced a Swiss team completed a study testing the use of non-invasive transcranial MRgFUS for the treatment of neuropathic pain InSightec Ltd. announced that a team at the University Children's ...

6. FDA Approves Label Change For Non-Invasive Fibroid Treatment
(Company News/InSightec)

InSightec Ltd. announced that the U.S. FDA approved a label change for the company’s ExAblate® 2000 MRgFUS system for the treatment of women with non-hysteroscopically resectable uterine fibroids.  ...

7. Noninvasive ExAblate® Treatment for Uterine Fibroids is Cost-Effective, New Study Says
(Communities/Ultrasound)

... ExAblate® 2000 Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system is more cost-effective than myomectomy or Uterine Artery Embollization (UAE). The study appears in the January 2009 issue (Vol. ...

8. Capstone RSNA 2008 Review
(Radiology Conferences/RSNA 2008)

... than previously reported. Not to overshadow RSNA itself, where MedicExchange covered prominent studies such as a *doubling in NPV results* from use of MRgFUS for uterine fibroids. An important market launch ...

9. MRgFUS Shrinks Uterine Fibroids by 33%, Study Shows
(Radiology Conferences/RSNA 2008)

Magnetic resonance-guided focused ultrasound (MRgFUS) treatment of uterine fibroids in an outpatient practice can yield significantly greater non-perfused volume (NPV) and shrinkage than other methods, ...

10. Doubled Results from Prior 15% to Current Average of 33% NPV Use of MRgFUS for Uterine Fibroids
(Radiology Conferences/RSNA 2008)

Magnetic resonance-guided focused ultrasound (MRgFUS) treatment of uterine fibroids in an outpatient practice can yield net perfused volume (NPV) and shrinkage greater than previous results, according ...

11. Major surgery no longer needed for the removal of uterine fibroids
(Radiology Conferences/ARRS 2008)

The treatment of uterine fibroids with 3T MR-guided focused ultrasound (MRgFUS) is safe, non-invasive and effective, according to a recent study conducted by researchers in New York, NY. The treatment ...

12. Enhanced MR-guided focused ultrasound guidelines demonstrate improved efficacy and durability
(Communities/Ultrasound)

A poster presented at the American College of Obstetrics and Gynecology (ACOG) annual meeting showed that women undergoing MRgFUS experience rapid and sustained relief from their condition and have a reduced ...

13. Medicare proposed HOPPS changes for 2008
(Radiology News/Radiology Articles)

... payment rate for APC 0282 is $105.48. Ultrasound ablation of uterine fibroids with magnetic resonance guidance (MRgFUS) (APCs 0195 and 0202) CMS is proposing to accept the APC Panel's recommendation ...

14. Insightec encourages uterine fibroid sufferers to ask their doctors about less invasive treatment options
(Imported/Imported)

... breakthrough MRgFUS technology that combines MRI - to visualize tissues in the body, plan the treatment and monitor in real time treatment outcome - and high intensity focused ultrasound to thermally ablate ...

15. Fighting fibroids: Phoenix area gynecologists now treat severely symptomatic tumors without surgery
(Imported/Imported)

... system to use the breakthrough MR-guided Focused Ultrasound (MRgFUS) technology that combines MRI – to visualize tissues in the body, plan the treatment and monitor, in real time, treatment outcome – and ...

16. Focused ultrasound relieves fibroid symptoms in women
(Communities/Ultrasound)

... of the journal Radiology. Magnetic resonance-guided, focused ultrasound surgery (MRgFUS) allows radiologists to precisely target fibroids without harming healthy surrounding tissue. “This treatment ...

17. Focused ultrasound treatment of uterine fibroid tumors provides long term symptom relief
(Communities/Ultrasound)

... imaging guided focused ultrasound surgery (MRgFUS) -- also shows that the more completely tumors are destroyed by focused ultrasound, the more durable the symptom relief. In addition, the incidence of ...

18. InSightec resumes clinical trials for non-invasive treatment of brain tumors
(Company News/InSightec)

... the safety profile submitted for review, the FDA recently approved the continuation of the trial. "The ExAblate MRgFUS technology has significant potential as a non-invasive and non-ionizing tumor therapy, ...

19. MR-guided ultrasound surgery of uterine fibroids is cost-effective
(Communities/Ultrasound)

Surgical management of symptomatic uterine fibroids can be accomplished cost-effectively with magnetic resonance-guided focused ultrasound surgery (MRgFUS), Canadian and British investigators report.  ...

20. First US patient undergoes non-invasive magnetic resonance-guided focused ultrasound procedure to relieve pain from bone metastases
(Communities/Ultrasound)

InSightec Ltd. announced today that the first US patient has been treated in the company's pivotal trial of the MRgFUS system as pain relieving treatment from bone metastases. InSightec Ltd. announced ...